Latest Research Publications - Life Science Network

Heads up!

This list contains publications from the last 7 days only, with a maximum of 10,000 items. Use the search function to access older publications.

The default sorting of articles in this list is by the date when the article was uploaded or imported to our database (shown on top). Publication date is indicated below the title.

Created 07 Sep 2026

Triglyceride-glucose related indices, cardiometabolic multimorbidity, and risk of incident osteoarthritis: A prospective cohort study in UK Biobank.

by Kai-Bo Sun, Yuan-Gang Wu, Yu-Huan Xiang, Meng-Ying Li, Yang Ding, Ling-Sheng Zhang, Yi Zeng, Hui-Qi Xie, Bin Shen — Therapeutic advances in musculoskeletal disease. Volume 18: 1759720X261485407. Epub Sep 03, 2026.
- Views 2
- More stats
- - Report or request
Created 07 Sep 2026

A novel glutamine metabolism-based classification system for characterizing the heterogeneity of hepatocellular carcinoma.

by Meijun Li, Zhiyi Chen, Xudong Shen, Zhenyu Feng, Shaohua Wei, Yecheng Li, Minjian Zhang, Zhenyu Ye — Journal of gastrointestinal oncology. Volume 17(4): 258. Aug 31, 2026.
- Views 1
- More stats
- - Report or request
Created 07 Sep 2026

Prognostic significance of lymphovascular invasion in colorectal mucinous adenocarcinoma after curative resection: a nationwide multi-center retrospective cohort study.

by Tianhao Wang, Bin Ren, Haoqing He, Peng Zhang, Changqing Jing, Xu Guan, Yueming Sun, Yifei Zhang, Shanglei Ning, Minhao Yu, Yanfeng Lv, Lei Wang, Meng Jiao, Yanlai Sun, Qi Sun, Dongning Liu, Xianghai Ren, Zhibin Ye, Zhao Zhang, Jun Li, Bin Ma, Guodong Yu, Wei Fu, Guangyong Zhang, Hui Yang — Journal of gastrointestinal oncology. Volume 17(4): 234. Aug 31, 2026.
- Views 1
- More stats
- - Report or request
Created 07 Sep 2026

Hydroxysafflor yellow A attenuates TBHP-induced lipid peroxidation and calcification-related changes in human endplate chondrocytes: involvement of SLC7A11/GPX4 signaling.

by Zongyu Zhang, Peng Zhang, Zhijing Zhou, Xuefeng Li, Yongfeng Huo — Cytotechnology. Volume 78(5): 195. Epub Sep 05, 2026.
- Views 1
- More stats
- - Report or request
Created 07 Sep 2026

Efficacy and safety of sintilimab-based neoadjuvant regimens in patients with resectable gastric or gastroesophageal junction adenocarcinoma: a single-arm systematic review and meta-analysis.

by Tingting Nan, Siheng Lian, Xiaohong Wu, Ruina Cai, Yumei Cai, Yonglong Su, Xiaoyun Ye, Yuhong Huang, Jinbao Wei, Ruping Ni — Journal of gastrointestinal oncology. Volume 17(4): 208. Aug 31, 2026.
- Views 1
- More stats
- - Report or request
Created 07 Sep 2026

FANCI promotes esophageal squamous cell carcinoma progression and cell cycle regulation and interacts with FANCD2.

by Beibei Hua, Tao Ye, Huijie Huang, Weiwei Wang, Xuezhi Chang, Ruozheng Wang — Journal of gastrointestinal oncology. Volume 17(4): 206. Aug 31, 2026.
- Views 2
- More stats
- - Report or request
Created 07 Sep 2026

A CFH- and SPINT2-based prognostic signature for cholangiocarcinoma.

by Sen Chen, Weiyang Ma, Beiqi Li, Jie Zhang, Wenxi Xie — Journal of gastrointestinal oncology. Volume 17(4): 259. Aug 31, 2026.
- Views 2
- More stats
- - Report or request
Created 07 Sep 2026

Construction of molecular signatures based on the co-expression network of NECSO-related gene TRPM4 and its prognostic value in hepatocellular carcinoma.

by Junze Chen, Jiamei Li, Zhiyong Lin, Cheng Zhang, Yongyuan Jian, Kaiyong Huang, Ruiling Su, Xuelin Tan, Xianxiang Chen, Mei Yao — Journal of gastrointestinal oncology. Volume 17(4): 254. Aug 31, 2026.
- Views 2
- More stats
- - Report or request
Created 07 Sep 2026

Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.

by Lujun Shen, Letao Lin, Yujie Zhang, Xiaoqiang Fang, Huijuan Lan, Weijun Fan — Journal of gastrointestinal oncology. Volume 17(4): 267. Aug 31, 2026.
- Views 1
- More stats
- - Report or request
Created 07 Sep 2026

Down-regulation of AGXT2L1 promotes the development of nonalcoholic fatty liver disease.

by Yue Yu, Lu Wu — Iranian journal of basic medical sciences. Volume 29(9): 1390-1397.
- Views 2
- More stats
- - Report or request

1
2
3
118
119
120
121
122
998
999
1000

Publications

Heads up!

Triglyceride-glucose related indices, cardiometabolic multimorbidity, and risk of incident osteoarthritis: A prospective cohort study in UK Biobank.

A novel glutamine metabolism-based classification system for characterizing the heterogeneity of hepatocellular carcinoma.

Prognostic significance of lymphovascular invasion in colorectal mucinous adenocarcinoma after curative resection: a nationwide multi-center retrospective cohort study.

Hydroxysafflor yellow A attenuates TBHP-induced lipid peroxidation and calcification-related changes in human endplate chondrocytes: involvement of SLC7A11/GPX4 signaling.

Efficacy and safety of sintilimab-based neoadjuvant regimens in patients with resectable gastric or gastroesophageal junction adenocarcinoma: a single-arm systematic review and meta-analysis.

FANCI promotes esophageal squamous cell carcinoma progression and cell cycle regulation and interacts with FANCD2.

A CFH- and SPINT2-based prognostic signature for cholangiocarcinoma.

Construction of molecular signatures based on the co-expression network of NECSO-related gene TRPM4 and its prognostic value in hepatocellular carcinoma.

Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.

Down-regulation of AGXT2L1 promotes the development of nonalcoholic fatty liver disease.